Anti-malarial Drugs Market Report

Europe Anti-malarial Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 13, 2020
  • PAGES：146
  • REPORT CODE：GMM434443
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Anti-malarial Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Anti-malarial Drugs Market Segmentations:

    By Player:

    • Merck KGaA.

    • Pfizer, Inc

    • GlaxoSmithKline Plc

    • Ranbaxy Laboratories

    • Ipca Laboratories Ltd

    • Zydus Cadila

    • Alvizia Health Care

    • Bayer AG

    • F Hoffmann-La Roche AG

    • F. Hoffmann-La Roche AG

    By Type:

    • Quinine

    • Chloroquine

    • Pyrimethamine

    • Amodiaquine

    • Proguanil

    • Mefloquine

    • Sulfonamide

    • Other

    By End-User:

    • Falciparum Malaria

    • Vivax Malaria

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-malarial Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Anti-malarial Drugs Market Size and Growth Rate of Quinine from 2014 to 2026

    • 1.3.2 Europe Anti-malarial Drugs Market Size and Growth Rate of Chloroquine from 2014 to 2026

    • 1.3.3 Europe Anti-malarial Drugs Market Size and Growth Rate of Pyrimethamine from 2014 to 2026

    • 1.3.4 Europe Anti-malarial Drugs Market Size and Growth Rate of Amodiaquine from 2014 to 2026

    • 1.3.5 Europe Anti-malarial Drugs Market Size and Growth Rate of Proguanil from 2014 to 2026

    • 1.3.6 Europe Anti-malarial Drugs Market Size and Growth Rate of Mefloquine from 2014 to 2026

    • 1.3.7 Europe Anti-malarial Drugs Market Size and Growth Rate of Sulfonamide from 2014 to 2026

    • 1.3.8 Europe Anti-malarial Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Anti-malarial Drugs Market Size and Growth Rate of Falciparum Malaria from 2014 to 2026

    • 1.4.2 Europe Anti-malarial Drugs Market Size and Growth Rate of Vivax Malaria from 2014 to 2026

    • 1.4.3 Europe Anti-malarial Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Anti-malarial Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Anti-malarial Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Quinine

      • 3.4.2 Market Size and Growth Rate of Chloroquine

      • 3.4.3 Market Size and Growth Rate of Pyrimethamine

      • 3.4.4 Market Size and Growth Rate of Amodiaquine

      • 3.4.5 Market Size and Growth Rate of Proguanil

      • 3.4.6 Market Size and Growth Rate of Mefloquine

      • 3.4.7 Market Size and Growth Rate of Sulfonamide

      • 3.4.8 Market Size and Growth Rate of Other

    4 Segmentation of Anti-malarial Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Anti-malarial Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Anti-malarial Drugs for Falciparum Malaria

      • 4.4.2 Market Size and Growth Rate of Anti-malarial Drugs for Vivax Malaria

      • 4.4.3 Market Size and Growth Rate of Anti-malarial Drugs for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Anti-malarial Drugs Production Analysis by Top Regions

    • 5.2 Europe Anti-malarial Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Anti-malarial Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Anti-malarial Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Anti-malarial Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Anti-malarial Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Anti-malarial Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Anti-malarial Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Anti-malarial Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Anti-malarial Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Anti-malarial Drugs Landscape Analysis

    • 7.1 Germany Anti-malarial Drugs Landscape Analysis by Major Types

    • 7.2 Germany Anti-malarial Drugs Landscape Analysis by Major End-Users

    8. UK Anti-malarial Drugs Landscape Analysis

    • 8.1 UK Anti-malarial Drugs Landscape Analysis by Major Types

    • 8.2 UK Anti-malarial Drugs Landscape Analysis by Major End-Users

    9. France Anti-malarial Drugs Landscape Analysis

    • 9.1 France Anti-malarial Drugs Landscape Analysis by Major Types

    • 9.2 France Anti-malarial Drugs Landscape Analysis by Major End-Users

    10. Italy Anti-malarial Drugs Landscape Analysis

    • 10.1 Italy Anti-malarial Drugs Landscape Analysis by Major Types

    • 10.2 Italy Anti-malarial Drugs Landscape Analysis by Major End-Users

    11. Spain Anti-malarial Drugs Landscape Analysis

    • 11.1 Spain Anti-malarial Drugs Landscape Analysis by Major Types

    • 11.2 Spain Anti-malarial Drugs Landscape Analysis by Major End-Users

    12. Poland Anti-malarial Drugs Landscape Analysis

    • 12.1 Poland Anti-malarial Drugs Landscape Analysis by Major Types

    • 12.2 Poland Anti-malarial Drugs Landscape Analysis by Major End-Users

    13. Russia Anti-malarial Drugs Landscape Analysis

    • 13.1 Russia Anti-malarial Drugs Landscape Analysis by Major Types

    • 13.2 Russia Anti-malarial Drugs Landscape Analysis by Major End-Users

    14. Switzerland Anti-malarial Drugs Landscape Analysis

    • 14.1 Switzerland Anti-malarial Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Anti-malarial Drugs Landscape Analysis by Major End-Users

    15. Turkey Anti-malarial Drugs Landscape Analysis

    • 15.1 Turkey Anti-malarial Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Anti-malarial Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Anti-malarial Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Anti-malarial Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Anti-malarial Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Anti-malarial Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Anti-malarial Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Anti-malarial Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Anti-malarial Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Anti-malarial Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Anti-malarial Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Anti-malarial Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Anti-malarial Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Merck KGaA.

      • 19.1.1 Merck KGaA. Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Pfizer, Inc

      • 19.2.1 Pfizer, Inc Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GlaxoSmithKline Plc

      • 19.3.1 GlaxoSmithKline Plc Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Ranbaxy Laboratories

      • 19.4.1 Ranbaxy Laboratories Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Ipca Laboratories Ltd

      • 19.5.1 Ipca Laboratories Ltd Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Zydus Cadila

      • 19.6.1 Zydus Cadila Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Alvizia Health Care

      • 19.7.1 Alvizia Health Care Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Bayer AG

      • 19.8.1 Bayer AG Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 F Hoffmann-La Roche AG

      • 19.9.1 F Hoffmann-La Roche AG Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 F. Hoffmann-La Roche AG

      • 19.10.1 F. Hoffmann-La Roche AG Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 74 Figures and 142 Tables)

    • Figure Product Picture

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Quinine from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Chloroquine from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Pyrimethamine from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Amodiaquine from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Proguanil from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Mefloquine from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Sulfonamide from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Falciparum Malaria from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Vivax Malaria from 2014 to 2026

    • Figure Europe Anti-malarial Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Anti-malarial Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Anti-malarial Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Anti-malarial Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Anti-malarial Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Anti-malarial Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Quinine

    • Figure Market Size and Growth Rate of Chloroquine

    • Figure Market Size and Growth Rate of Pyrimethamine

    • Figure Market Size and Growth Rate of Amodiaquine

    • Figure Market Size and Growth Rate of Proguanil

    • Figure Market Size and Growth Rate of Mefloquine

    • Figure Market Size and Growth Rate of Sulfonamide

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Anti-malarial Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Anti-malarial Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Falciparum Malaria

    • Figure Market Size and Growth Rate of Vivax Malaria

    • Figure Market Size and Growth Rate of Others

    • Table Europe Anti-malarial Drugs Production by Major Regions

    • Table Europe Anti-malarial Drugs Production Share by Major Regions

    • Figure Europe Anti-malarial Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Anti-malarial Drugs Consumption by Major Regions

    • Table Europe Anti-malarial Drugs Consumption Share by Major Regions

    • Table Germany Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table UK Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table France Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Anti-malarial Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Anti-malarial Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Anti-malarial Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Anti-malarial Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Germany Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table UK Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table France Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table France Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table France Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Italy Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Spain Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Poland Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Russia Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-malarial Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-malarial Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Anti-malarial Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Anti-malarial Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Merck KGaA.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA.

    • Figure Sales and Growth Rate Analysis of Merck KGaA.

    • Figure Revenue and Market Share Analysis of Merck KGaA.

    • Table Product and Service Introduction of Merck KGaA.

    • Table Company Profile and Development Status of Pfizer, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc

    • Figure Revenue and Market Share Analysis of Pfizer, Inc

    • Table Product and Service Introduction of Pfizer, Inc

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Ranbaxy Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ranbaxy Laboratories

    • Figure Sales and Growth Rate Analysis of Ranbaxy Laboratories

    • Figure Revenue and Market Share Analysis of Ranbaxy Laboratories

    • Table Product and Service Introduction of Ranbaxy Laboratories

    • Table Company Profile and Development Status of Ipca Laboratories Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipca Laboratories Ltd

    • Figure Sales and Growth Rate Analysis of Ipca Laboratories Ltd

    • Figure Revenue and Market Share Analysis of Ipca Laboratories Ltd

    • Table Product and Service Introduction of Ipca Laboratories Ltd

    • Table Company Profile and Development Status of Zydus Cadila

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Cadila

    • Figure Sales and Growth Rate Analysis of Zydus Cadila

    • Figure Revenue and Market Share Analysis of Zydus Cadila

    • Table Product and Service Introduction of Zydus Cadila

    • Table Company Profile and Development Status of Alvizia Health Care

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alvizia Health Care

    • Figure Sales and Growth Rate Analysis of Alvizia Health Care

    • Figure Revenue and Market Share Analysis of Alvizia Health Care

    • Table Product and Service Introduction of Alvizia Health Care

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of F Hoffmann-La Roche AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG

    • Table Product and Service Introduction of F Hoffmann-La Roche AG

    • Table Company Profile and Development Status of F. Hoffmann-La Roche AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche AG

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche AG

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche AG

    • Table Product and Service Introduction of F. Hoffmann-La Roche AG

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US